Your browser doesn't support javascript.
loading
Immunogenicity to infliximab is associated with HLA-DRB1.
Billiet, Thomas; Vande Casteele, Niels; Van Stappen, Thomas; Princen, Fred; Singh, Sharat; Gils, Ann; Ferrante, Marc; Van Assche, Gert; Cleynen, Isabelle; Vermeire, Severine.
Afiliación
  • Billiet T; Department of Clinical and Experimental Medicine, Translational Research Center for GastroIntestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
  • Vande Casteele N; Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Van Stappen T; Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Princen F; Department of Research and Development, Prometheus Laboratories, San Diego, California, USA.
  • Singh S; Department of Research and Development, Prometheus Laboratories, San Diego, California, USA.
  • Gils A; Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Ferrante M; Department of Gastroenterology, UZ Leuven, Leuven, Belgium.
  • Van Assche G; Department of Gastroenterology, UZ Leuven, Leuven, Belgium.
  • Cleynen I; Department of Gastroenterology, UZ Leuven, Leuven, Belgium.
  • Vermeire S; Department of Gastroenterology, UZ Leuven, Leuven, Belgium.
Gut ; 64(8): 1344-5, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25876612

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Resistencia a Medicamentos / Colitis Ulcerosa / Enfermedad de Crohn / Antiinflamatorios no Esteroideos / Anticuerpos / Anticuerpos Monoclonales Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Gut Año: 2015 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Resistencia a Medicamentos / Colitis Ulcerosa / Enfermedad de Crohn / Antiinflamatorios no Esteroideos / Anticuerpos / Anticuerpos Monoclonales Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Gut Año: 2015 Tipo del documento: Article País de afiliación: Bélgica